MSD Fined €39m In Spain Over Blocking Nuvaring Rival
Insud Pharma’s Ornibel Version Suffered Following Originator Abuse Of Dominant Position
Spanish competition regulator the CNMC has fined Merck Sharp and Dohme €39m for abusing its dominant position, by blocking Insud Pharma’s rival to the Nuvaring vaginal contraceptive ring through “unjustified legal action” that sought to delay market entry of Insud’s Ornibel version. The originator is considering an appeal.
